Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001493152-26-008874·Akari Therapeutics Plc
Schedule 13D ownership disclosure
AKARI THERAPEUTICS PLC
Ordinary Shares, $0.000000005 par value · CUSIP: 00972G207
Event date: 2026-03-02
- Filing-level shares
- 9,725,215,000.00
- Percent of class
- 10.4%
- Samir R. PatelReported CIK 0001702447
Shares: 9,725,215,000.00 · Class: 10.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-26-008874
- Form type
- SCHEDULE 13D/A
- Filer
- Akari Therapeutics Plc
- CIK
- CIK 1541157
- Filed
- Mar 04, 2026
- Reporting period
- Mar 02, 2026
- Description
- Schedule 13D beneficial ownership